arXiv subjects

Sally Blower

Publications and source records attributed to Sally Blower.

4 recordsLinked to original sources

arXiv2006

The Vaccinee's Dilemma: Individual-level Decisions, Self- Organization & Influenza Epidemics

Inspired by Minority Games, we constructed a novel individual-level game of adaptive decision-making based on the dilemma of deciding whether to participate in voluntary influenza vaccination programs. The proportion of the population vaccinated (i.e., the vaccination coverage) determines epidemic severity. Above a critical vaccination coverage, epidemics are prevented; hence individuals find it unnecessary to vaccinate. The adaptive dynamics of the decisions directly affect influenza epidemiology and, conversely, influenza epidemiology strongly influences decision-making. This feedback mechanism creates a unique self-organized state where epidemics are prevented. This state is attracting, but unstable; thus epidemics are rarely prevented. This result implies that vaccination will have to be mandatory if the public health objective is to prevent influenza epidemics. We investigated how collective behavior changes when public health programs are implemented. Surprisingly, programs requiring advance payment for several years of vaccination prevents severe epidemics, even with voluntary vaccination. Prevention is determined by the individuals' adaptability, memory, and number of pre-paid vaccinations. Notably, vaccinating families exacerbates and increases the frequency of severe epidemics.

q-bio.PE↗

arXiv2006

Inductive Reasoning Games as Influenza Vaccination Models: Mean Field Analysis

We define and analyze an inductive reasoning game of voluntary yearly vaccination in order to establish whether or not a population of individuals acting in their own self-interest would be able to prevent influenza epidemics. We find that epidemics are rarely prevented. We also find that severe epidemics may occur without the introduction of pandemic strains. We further address the situation where market incentives are introduced to help ameliorating epidemics. Surprisingly, we find that vaccinating families exacerbates epidemics. However, a public health program requesting prepayment of vaccinations may significantly ameliorate influenza epidemics.

q-bio.PE↗

arXiv2005

The WHO surveillance threshold and the emergence of drug-resistant HIV strains in Botswana

Background: Approximately 40% of adults in Botswana are HIV-infected. The Botswana antiretroviral program began in 2002 and currently treats 34,000 patients with a goal of treating 85,000 patients (~30% of HIV-infected adults) by 2009. We predict the evolution of drug-resistant strains of HIV that may emerge as a consequence of this treatment program. We discuss the implications of our results for the World Health Organization's (WHO's) proposed surveillance system for detecting drug-resistant strains of HIV in Africa. Methods: We use a mathematical model of the emergence of drug resistance. We incorporate demographic and treatment data to make specific predictions as to when the WHO surveillance threshold is likely to be exceeded. Results: Our results show - even if rates of acquired resistance are high, but the drug-resistant strains that evolve are only half as transmissible as wild-type strains - that transmission of drug-resistant strains will remain low (< 5% by 2009) and are unlikely to exceed the WHO's surveillance threshold. However,our results show that transmission of drug-resistant strains in Botswana could increase to ~15% by 2009 if resistant strains are as transmissible as wild-type strains. Conclusion: The WHO's surveillance system is designed to detect transmitted resistance that exceeds a threshold level of 5%. Whether this system will detect drug-resistant strains in Botswana by 2009 will depend upon the transmissibility of the strains that emerge. Our results imply that it could be many years before the WHO detects transmitted resistance in other sub-Saharan African countries with less ambitious treatment programs than Botswana.

q-bio.PE↗

arXiv2005

Parametric Resonance May Explain Virologic Failure to HIV Treatment Interruptions

Pilot studies of structured treatment interruptions (STI) in HIV therapy have shown that patients can maintain low viral loads whilst benefiting from reduced treatment toxicity. However, a recent STI clinical trial reported a high degree of virologic failure. Here we present a novel hypothesis that could explain virologic failure to STI and provides new insights of great clinical relevance. We analyze a classic mathematical model of HIV within-host viral dynamics and find that nonlinear parametric resonance occurs when STI are added to the model; resonance is observed as virologic failure. We use the model to simulate clinical trial data and to calculate patient-specific resonant spectra. We gain two important insights. Firstly, within an STI trial, we determine that patients who begin with similar viral loads can be expected to show extremely different virologic responses as a result of resonance. Thus, high heterogeneity of patient response within a STI clinical trial is to be expected. Secondly and more importantly, we determine that virologic failure is not simply due to STI or patient characteristics; rather it is the result of a complex dynamic interaction between STI and patient viral dynamics. Hence, our analyses demonstrate that no universal regimen with periodic interruptions will be effective for all patients. On the basis of our results, we suggest that immunologic and virologic parameters should be used to design patient-specific STI regimens.

q-bio.PE↗